Evidence map›Paper›PMID 32122897›Full record

ArticleAntimicrobial agents and chemotherapy2020

Charbel Al Khoury, Nabil Nemer, Georges Nemer, Mazen Kurban, Charlotte Bernigaud, Katja Fischer, Jacques Guillot

Open access · greenAbstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.4field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 21 citations in OpenAlex.

  1. Current research in parasitology & vector-borne diseases · 2025
    Article
  2. Evaluation of Beauvericin's activity and mode of action against all life stages ofFrontiers in cellular and infection microbiology · 2025
    Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Pathogens (Basel, Switzerland) · 2021
    Review
  9. Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 6 institutions in 3 countries.

Charbel Al KhouryFaculty of Agricultural and Food Sciences, Holy Spirit University of Kaslik, Jounieh, Lebanon.
Nabil NemerFaculty of Agricultural and Food Sciences, Holy Spirit University of Kaslik, Jounieh, Lebanon.
Georges NemerDepartment of Biochemistry and Molecular Genetics, American University of Beirut, Beirut, Lebanon.
Mazen KurbanDepartment of Biochemistry and Molecular Genetics, American University of Beirut, Beirut, Lebanon.
Charlotte BernigaudResearch Group Dynamyc, EA7380, Université Paris-Est Créteil, Ecole Nationale Vétérinaire d'Alfort, USC ANSES, Maisons-Alfort, France.
Katja FischerScabies Laboratory, QIMR Berghofer Medical Research Institute, Infectious Diseases Program, Brisbane, Australia.
Jacques GuillotResearch Group Dynamyc, EA7380, Université Paris-Est Créteil, Ecole Nationale Vétérinaire d'Alfort, USC ANSES, Maisons-Alfort, France jacques.guillot@vet-alfort.fr.
American University of Beirut · LBAssistance Publique – Hôpitaux de Paris · FRÉcole Nationale Vétérinaire d'Alfort · FRHoly Spirit University of Kaslik · LBQIMR Berghofer Medical Research Institute · AUUniversité Paris-Est Créteil · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Scabies is a frequent cutaneous infection caused by the mite

Indexed as

Drug ResistanceAcaricidesAnimalsCells, CulturedDepsipeptidesDiazinonFibroblastsHumansIvermectinLarvaOvumSarcoptes scabieiScabiesSkinSwineAcaricidesbeauvericinDepsipeptidesDiazinonIvermectinacaricidebeauvericinin vitro testmycotoxinSarcoptes scabieiscabies

Identifiers

PMID32122897
PMCPMC7179650
OpenAlexW3008665435

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.